DeGolyer Donald W
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to DeGolyer Donald W. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| EBS | Sale | 17,801 | $10.54 | $187,623 | Nov 10, 2025 | |
| EBS | Sale | 7,844 | $8.65 | $67,851 | Aug 12, 2025 | |
| EBS | Award / Grant | 34,403 | — | — | Apr 30, 2025 | |
| EBS | Sale | 25,000 | $10.91 | $272,750 | Nov 12, 2024 | |
| EBS | Award / Grant | 17,430 | — | — | May 23, 2024 | |
| EBS | Award / Grant | 118,670 | — | — | Oct 3, 2023 | |
| 0001593034 | Chief Operating Officer,Pharma | Tax Withholding | 477 | $85.19 | $40,636 | Feb 26, 2015 |
| 0001593034 | Chief Operating Officer,Pharma | Tax Withholding | 4,459 | $68.10 | $303,658 | Aug 2, 2014 |
| 0001593034 | Chief Operating Officer,Pharma | Award / Grant | 30,604 | — | — | Feb 28, 2014 |
| 0001100962 | Chief Operating Officer,Pharma | Disposition | 10,242 | — | — | Feb 28, 2014 |
| 0001100962 | Chief Operating Officer,Pharma | Award / Grant | 5,121 | — | — | Feb 26, 2014 |